Back to Agenda
China Town Hall
Session Chair(s)
Ling Su, PHD
Research Fellow, Yeehong Business School, China
In this forum, speakers from the National Medical Products Administration (NMPA) and the Center for Drug Evaluation (CDE) will present and discuss the latest information on regulation, regulatory science, and drug review and approval. Speakers will also discuss recent development in clinical research in China. Attendees will have an opportunity to discuss the issues related to drug regulation with NMPA officials.
Learning Objective : Describe the latest information on the National Medical Products Administration’s activities in drug regulation; Describe the recent update on the progress in drug review, approval and clinical research in China; Identify challenges in drug development and regulation in China.
Speaker(s)
Opening Remarks and Introductions
Deputy Director, China Center for Food and Drug International Exchange, National Medical Products, China
Initiatives to Bring More New Drugs to Patients, and Faster
Deputy Director, Center for Drug Evaluation, National Medical Products Administration (NMPA), China
Recent Developments in Regulatory Science and Regulation
Director, Department of Drug Registration, National Medical Products Administration (NMPA), China
Advancing Clinical Research in China: A Clinical Oncologist’s Perspective
Director, Center for Clinical Medicine of Lung Cancer, Shanghai Chest Hospital,, Shanghai Jiaotong University, China
Have an account?